In prostate cancer, tumor cells released IL-6 leading to fibroblasts activation, and in turn, fibroblasts, through MMPs secretion, elicited an EMT phenotype in cancer cells, as well as enhancement of tumor growth and development of spontaneous metastases. Here, IL6 is linked to prostate carcinoma.